Literature DB >> 29343850

MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.

Yi Niu1, Yan Jin1, Shi-Chang Deng1, Shi-Jiang Deng1, Shuai Zhu1, Yang Liu1, Xiang Li1, Chi He1, Ming-Liang Liu1, Zhu Zeng1, Heng-Yu Chen1, Jian-Xin Zhong1, Zeng Ye1, Chun-You Wang1, Gang Zhao2.   

Abstract

Migration and invasion inhibitory protein (MIIP) is recently identified as an inhibitor in tumor development. However, the regulatory mechanism and biological contributions of MIIP in pancreatic cancer (PC) have been not elucidated. In this study, we demonstrated a negative feedback of MIIP and hypoxia-induced factor-1α (HIF-1α), which was mediated by a hypoxia-induced microRNA. Compared with paracarcinoma tissues, MIIP was downregulated in PC tissues. Overexpression of MIIP significantly impeded the proliferation and invasion of PC cells both in vitro and in mouse xenograft models. We further verified MIIP was downregulated under hypoxia in a HIF-1α-mediated manner. Interestingly, although MIIP promoter containing two putative hypoxia response elements (HREs), the chromatin immunoprecipitation (ChIP) and luciferase reporter assays did not support an active interaction between HIF-1α and MIIP promoter. Meanwhile, microRNA array revealed a hypoxia-induced microRNA, miR-646, impaired stability of MIIP mRNA and consequently inhibited its expression by targeting the coding sequence (CDS). Coincidently, knockdown of miR-646 significantly repressed proliferation and invasion ability of PC cells both in vitro and in vivo by upregulating MIIP expression. Besides, ChIP and luciferase reporter assays further validated that HIF-1α activated transcription of miR-646 in hypoxia condition. Therefore, these results suggested HIF-1α indirectly regulated MIIP expression in post-transcriptional level through upregulating miR-646 transcription. Conversely, our results further revealed that MIIP suppressed deacetylase ability of histone deacetylase 6 (HDAC6) to promote the acetylation and degradation of HIF-1α, by which impairing HIF-1α accumulation. What is more, a specific relationship between downregulated MIIP and upregulated miR-646 expression was validated in PC samples. Moreover, the dysregulated miR-646 and MIIP expression was correlated with advanced tumor stage, lymphatic invasion, metastasis and shorter overall survival in PC patients. Together, our results highlight that the reciprocal loop of HIF-1α/miR-646/MIIP might be implemented as an applicable target for pancreatic cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29343850     DOI: 10.1038/s41388-017-0082-2

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

Review 1.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

2.  Functional microRNA targets in protein coding sequences.

Authors:  Martin Reczko; Manolis Maragkakis; Panagiotis Alexiou; Ivo Grosse; Artemis G Hatzigeorgiou
Journal:  Bioinformatics       Date:  2012-01-27       Impact factor: 6.937

Review 3.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

4.  Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.

Authors:  Y Liu; X Li; S Zhu; J-g Zhang; M Yang; Q Qin; S-c Deng; B Wang; K Tian; L Liu; Y Niu; C-y Wang; G Zhao
Journal:  Gene Ther       Date:  2015-04-28       Impact factor: 5.250

5.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

6.  Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells.

Authors:  Thomas A Mace; Amy L Collins; Sylwia E Wojcik; Carlo M Croce; Gregory B Lesinski; Mark Bloomston
Journal:  J Surg Res       Date:  2013-05-18       Impact factor: 2.192

7.  Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation.

Authors:  Jean Hausser; Afzal Pasha Syed; Biter Bilen; Mihaela Zavolan
Journal:  Genome Res       Date:  2013-01-18       Impact factor: 9.043

8.  MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  RNA       Date:  2014-07-01       Impact factor: 4.942

9.  Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

Authors:  W Li; M Liu; Y Feng; Y-F Xu; Y-F Huang; J-P Che; G-C Wang; X-D Yao; J-H Zheng
Journal:  Br J Cancer       Date:  2014-07-10       Impact factor: 7.640

10.  Association between a variant in microRNA-646 and the susceptibility to hepatocellular carcinoma in a large-scale population.

Authors:  Rui Wang; Jun Zhang; Weiru Jiang; Yanyun Ma; Wenshuai Li; Bohan Jin; Heping Hu; Jiucun Wang; Yi Liu; Jie Liu
Journal:  ScientificWorldJournal       Date:  2014-08-07
View more
  22 in total

1.  MIIP inhibits EMT and cell invasion in prostate cancer through miR-181a/b-5p-KLF17 axis.

Authors:  Wei Hu; Fengqi Yan; Yi Ru; Mingyuan Xia; Guang Yan; Mei Zhang; He Wang; Guojun Wu; Libo Yao; Lan Shen; Xia Li; Qinhao Wang
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

2.  MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.

Authors:  Yuxin Lin; Wentao Wu; Zhandong Sun; Li Shen; Bairong Shen
Journal:  RNA Biol       Date:  2018-09-17       Impact factor: 4.652

3.  WZY-321 triggers glioma cell apoptosis via XAF1 up-regulation caused by MTM-mediated miR-873 down-regulation.

Authors:  Guan Sun; Wei Yuan; Weiye Zhu; Jian Chen
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

4.  MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.

Authors:  Guang Yan; Yi Ru; Fengqi Yan; Xin Xiong; Wei Hu; Tao Pan; Jianming Sun; Chi Zhang; Qinhao Wang; Xia Li
Journal:  Cell Commun Signal       Date:  2019-05-15       Impact factor: 5.712

Review 5.  The interplay between HIF-1α and noncoding RNAs in cancer.

Authors:  Xiafeng Peng; Han Gao; Rui Xu; Huiyu Wang; Jie Mei; Chaoying Liu
Journal:  J Exp Clin Cancer Res       Date:  2020-02-03

6.  Genetic Polymorphism of rs13306146 Affects α2AAR Expression and Associated With Postpartum Depressive Symptoms in Chinese Women Who Received Cesarean Section.

Authors:  Kai Ming Duan; Chao Fang; Si Qi Yang; Shu Ting Yang; Ji Dong Xiao; Huang Chang; Guo Xin Lin; Liang Bin Zhang; Ming Chao Peng; Zhao Qian Liu; Sai Ying Wang
Journal:  Front Genet       Date:  2021-07-07       Impact factor: 4.599

7.  MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1.

Authors:  Shuo Chen; Meng Xu; Jing Zhao; Jiaqi Shen; Junhui Li; Yang Liu; Gang Cao; Jiancang Ma; Weizhou He; Xi Chen; Tao Shan
Journal:  Int J Biol Sci       Date:  2020-05-18       Impact factor: 6.580

Review 8.  Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer.

Authors:  Can Lu; Danting Zhou; Qiang Wang; Wenliang Liu; Fenglei Yu; Fang Wu; Chen Chen
Journal:  Oxid Med Cell Longev       Date:  2020-04-28       Impact factor: 6.543

9.  CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.

Authors:  Yao Liu; Shuo Chen; Zhi-Hong Zong; Xue Guan; Yang Zhao
Journal:  J Cell Mol Med       Date:  2020-05-07       Impact factor: 5.310

10.  hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma.

Authors:  Ling Wang; Guo-Chuan Zhang; Fu-Biao Kang; Long Zhang; Ying-Ze Zhang
Journal:  Biomed Res Int       Date:  2019-12-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.